.RESEARCH STUDY FEATURE.19 September 2024. Plozasiran lowered triglyceride levels through 80% and decreased the risk of pancreatitis in patients with consistent chylomicronemia, along with or without a genetic prognosis.
Offering a complete view on all topics, from current events and finance to technology, health, and lifestyle.
.RESEARCH STUDY FEATURE.19 September 2024. Plozasiran lowered triglyceride levels through 80% and decreased the risk of pancreatitis in patients with consistent chylomicronemia, along with or without a genetic prognosis.